Jeffrey P. George
CIK: 0001796789
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 15, 2026LENZ
LENZ Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
22.1K shares- - May 7, 2026AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Direct34.8K shares- - May 6, 2026AMRX
Amneal Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
19.8K shares- - Mar 27, 2026LENZ
LENZ Therapeutics, Inc.
Purchase(P)Direct5.6K shares at avg. $8.92$50K - Jun 12, 2025MASS
908 Devices Inc.
Award(A)DirectStock Option (option to buy)
6.5K shares- - Jun 12, 2025MASS
908 Devices Inc.
Award(A)DirectRestricted Stock Units
14.1K shares- - Jun 11, 2025MASS
908 Devices Inc.
Exercise(M)Direct11.4K shares- - Jun 11, 2025LENZ
LENZ Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
13.5K shares- - May 6, 2025AMRX
Amneal Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
34.8K shares- - May 5, 2025AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Direct40.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 |  LENZ LENZ Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 22,100 | - | - | Direct |
| May 7, 2026 |  AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 34,819 | - | $0 | Direct |
| May 6, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 19,824 | - | - | Direct |
| Mar 27, 2026 | LENZ LENZ Therapeutics, Inc. | Purchase(P) | 5,592 | $8.92 | $49,890 | Direct |
| Jun 12, 2025 |  MASS 908 Devices Inc. | Award(A) Stock Option (option to buy) | 6,516 | - | - | Direct |
| Jun 12, 2025 | MASS 908 Devices Inc. | Award(A) Restricted Stock Units | 14,083 | - | - | Direct |
| Jun 11, 2025 | MASS 908 Devices Inc. | Exercise(M) | 11,364 | - | - | Direct |
| Jun 11, 2025 | LENZ LENZ Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 13,500 | - | - | Direct |
| May 6, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 34,819 | - | - | Direct |
| May 5, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 40,258 | - | - | Direct |
1-10 of 10 transactions
About George Jeffrey P.
George Jeffrey P. (SEC CIK 0001796789) files insider reports with the SEC as Director of LENZ Therapeutics, Inc. (LENZ), Director of Amneal Pharmaceuticals, Inc. (AMRX) and Director of 908 Devices Inc. (MASS).
Signal8 holds 6 ownership filings by George Jeffrey P., all Form 4s, filed between May 8, 2025 and Jun 15, 2026. Those filings report 10 transactions, from May 5, 2025 to Jun 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on George Jeffrey P.'s filings is in SOLANA BEACH, CA.
Recent filings by George Jeffrey P.
- Jun 15, 2026: Grant or award of LENZ derivative securities (Form 4, code A).
- May 7, 2026: Option exercise of AMRX shares (Form 4, code M).
- May 6, 2026: Grant or award of AMRX derivative securities (Form 4, code A).
- Mar 27, 2026: Open-market purchase of LENZ shares (Form 4, code P).
- Jun 12, 2025: Grants or awards of MASS derivative securities (2 lines, Form 4, code A).
Other insiders filing for LENZ Therapeutics, Inc. (LENZ)
- Chevallard Daniel R., Chief Financial Officer
- RA CAPITAL MANAGEMENT, L.P., 10% Owner
- Drapkin Kimberlee C, Director
- MCCOLLUM JAMES W, Director
- Thunen Shelley B, Director
- Guerard Frederic, Director